vs

Side-by-side financial comparison of Babcock & Wilcox Enterprises, Inc. (BW) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.

AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $113.4M, roughly 1.6× Babcock & Wilcox Enterprises, Inc.). On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 0.6%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-7.2M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -16.9%).

Babcock & Wilcox Enterprises, Inc. is an American energy technology and service provider that is active and has operations in many international markets with its headquarters in Akron, Ohio. Historically, the company is best known for their steam boilers.

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

BW vs FOLD — Head-to-Head

Bigger by revenue
FOLD
FOLD
1.6× larger
FOLD
$185.2M
$113.4M
BW
Growing faster (revenue YoY)
FOLD
FOLD
+23.1% gap
FOLD
23.7%
0.6%
BW
More free cash flow
FOLD
FOLD
$23.1M more FCF
FOLD
$16.0M
$-7.2M
BW
Faster 2-yr revenue CAGR
FOLD
FOLD
Annualised
FOLD
29.5%
-16.9%
BW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BW
BW
FOLD
FOLD
Revenue
$113.4M
$185.2M
Net Profit
$1.7M
Gross Margin
20.6%
85.7%
Operating Margin
0.2%
8.6%
Net Margin
0.9%
Revenue YoY
0.6%
23.7%
Net Profit YoY
-88.5%
EPS (diluted)
$0.11
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BW
BW
FOLD
FOLD
Q4 25
$113.4M
$185.2M
Q3 25
$149.0M
$169.1M
Q2 25
$144.1M
$154.7M
Q1 25
$181.2M
$125.2M
Q4 24
$112.7M
$149.7M
Q3 24
$152.6M
$141.5M
Q2 24
$151.4M
$126.7M
Q1 24
$164.3M
$110.4M
Net Profit
BW
BW
FOLD
FOLD
Q4 25
$1.7M
Q3 25
$35.1M
$17.3M
Q2 25
$-58.5M
$-24.4M
Q1 25
$-22.0M
$-21.7M
Q4 24
$-63.1M
$14.7M
Q3 24
$-5.3M
$-6.7M
Q2 24
$25.4M
$-15.7M
Q1 24
$-16.8M
$-48.4M
Gross Margin
BW
BW
FOLD
FOLD
Q4 25
20.6%
85.7%
Q3 25
24.9%
88.5%
Q2 25
30.0%
90.2%
Q1 25
22.1%
90.7%
Q4 24
16.7%
90.1%
Q3 24
23.7%
90.6%
Q2 24
21.8%
91.1%
Q1 24
23.6%
87.7%
Operating Margin
BW
BW
FOLD
FOLD
Q4 25
0.2%
8.6%
Q3 25
4.4%
20.3%
Q2 25
5.6%
-6.1%
Q1 25
3.2%
-6.3%
Q4 24
-8.1%
10.7%
Q3 24
1.0%
15.3%
Q2 24
-2.9%
11.8%
Q1 24
3.5%
-25.1%
Net Margin
BW
BW
FOLD
FOLD
Q4 25
0.9%
Q3 25
23.5%
10.2%
Q2 25
-40.6%
-15.8%
Q1 25
-12.1%
-17.3%
Q4 24
-56.0%
9.8%
Q3 24
-3.5%
-4.8%
Q2 24
16.8%
-12.4%
Q1 24
-10.2%
-43.9%
EPS (diluted)
BW
BW
FOLD
FOLD
Q4 25
$0.11
$0.00
Q3 25
$0.30
$0.06
Q2 25
$-0.63
$-0.08
Q1 25
$-0.26
$-0.07
Q4 24
$-0.73
$0.05
Q3 24
$-0.10
$-0.02
Q2 24
$0.24
$-0.05
Q1 24
$-0.23
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BW
BW
FOLD
FOLD
Cash + ST InvestmentsLiquidity on hand
$89.5M
$293.5M
Total DebtLower is stronger
$392.7M
Stockholders' EquityBook value
$-131.5M
$274.2M
Total Assets
$662.9M
$949.9M
Debt / EquityLower = less leverage
1.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BW
BW
FOLD
FOLD
Q4 25
$89.5M
$293.5M
Q3 25
$25.2M
$263.8M
Q2 25
$23.4M
$231.0M
Q1 25
$23.5M
$250.6M
Q4 24
$26.9M
$249.9M
Q3 24
$30.6M
$249.8M
Q2 24
$95.5M
$260.1M
Q1 24
$43.9M
$239.6M
Total Debt
BW
BW
FOLD
FOLD
Q4 25
$392.7M
Q3 25
$392.0M
Q2 25
$391.3M
Q1 25
$390.7M
Q4 24
$390.1M
Q3 24
$389.5M
Q2 24
$388.9M
Q1 24
$388.4M
Stockholders' Equity
BW
BW
FOLD
FOLD
Q4 25
$-131.5M
$274.2M
Q3 25
$-232.2M
$230.4M
Q2 25
$-309.2M
$204.3M
Q1 25
$-303.0M
$193.6M
Q4 24
$-283.8M
$194.0M
Q3 24
$-203.7M
$178.8M
Q2 24
$-198.9M
$132.5M
Q1 24
$-223.0M
$130.7M
Total Assets
BW
BW
FOLD
FOLD
Q4 25
$662.9M
$949.9M
Q3 25
$657.9M
$868.8M
Q2 25
$703.5M
$815.3M
Q1 25
$719.7M
$789.8M
Q4 24
$727.0M
$785.0M
Q3 24
$804.6M
$786.6M
Q2 24
$849.1M
$749.5M
Q1 24
$795.5M
$721.8M
Debt / Equity
BW
BW
FOLD
FOLD
Q4 25
1.43×
Q3 25
1.70×
Q2 25
1.92×
Q1 25
2.02×
Q4 24
2.01×
Q3 24
2.18×
Q2 24
2.93×
Q1 24
2.97×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BW
BW
FOLD
FOLD
Operating Cash FlowLast quarter
$-3.0M
$16.3M
Free Cash FlowOCF − Capex
$-7.2M
$16.0M
FCF MarginFCF / Revenue
-6.3%
8.6%
Capex IntensityCapex / Revenue
3.7%
0.2%
Cash ConversionOCF / Net Profit
9.62×
TTM Free Cash FlowTrailing 4 quarters
$-85.7M
$29.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BW
BW
FOLD
FOLD
Q4 25
$-3.0M
$16.3M
Q3 25
$-32.1M
$35.7M
Q2 25
$-25.3M
$-26.5M
Q1 25
$-8.5M
$7.8M
Q4 24
$-22.5M
$-3.9M
Q3 24
$-69.5M
$-23.0M
Q2 24
$-11.8M
$22.7M
Q1 24
$-14.9M
$-29.7M
Free Cash Flow
BW
BW
FOLD
FOLD
Q4 25
$-7.2M
$16.0M
Q3 25
$-37.6M
$35.3M
Q2 25
$-28.1M
$-28.9M
Q1 25
$-12.8M
$7.5M
Q4 24
$-23.6M
$-4.2M
Q3 24
$-71.6M
$-23.3M
Q2 24
$-16.4M
$21.6M
Q1 24
$-18.3M
$-31.5M
FCF Margin
BW
BW
FOLD
FOLD
Q4 25
-6.3%
8.6%
Q3 25
-25.3%
20.9%
Q2 25
-19.5%
-18.7%
Q1 25
-7.1%
6.0%
Q4 24
-20.9%
-2.8%
Q3 24
-46.9%
-16.5%
Q2 24
-10.8%
17.0%
Q1 24
-11.2%
-28.5%
Capex Intensity
BW
BW
FOLD
FOLD
Q4 25
3.7%
0.2%
Q3 25
3.7%
0.2%
Q2 25
1.9%
1.6%
Q1 25
2.4%
0.2%
Q4 24
1.0%
0.2%
Q3 24
1.4%
0.3%
Q2 24
3.0%
0.9%
Q1 24
2.1%
1.6%
Cash Conversion
BW
BW
FOLD
FOLD
Q4 25
9.62×
Q3 25
-0.92×
2.06×
Q2 25
Q1 25
Q4 24
-0.27×
Q3 24
Q2 24
-0.46×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BW
BW

Construction$98.8M87%
Other$14.6M13%

FOLD
FOLD

Other$105.8M57%
Galafold$64.8M35%
Pombiliti Opfolda$14.6M8%

Related Comparisons